Clinical trial

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

NCT02316795

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2019-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Cancer of Breastunresolved

Cancer of the Breastunresolved

Melanomaunresolved

Malignant Melanomaunresolved

Interventions

Sentinel lymph node biopsyPROCEDURE

Goggle-based device with light-emitting diodes (LED)DEVICE

Indocynanine GreenDRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02316795 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.